Abstracts - faqs.org

Abstracts

Health

Search abstracts:
Abstracts » Health

Liver disease in patients with hereditary hemorrhagic telangiectasia

Article Abstract:

Cases of liver involvement in patients with hereditary Rendu-Osler-Weber disease indicate hepatic abnormalities. In a study of 19 patients with this autosomal disorder, clinical manifestations show a variety of conditions that include heart-failure, bile duct disease, and liver hypertension.

Author: Garcia-Tsao, Guadalupe, Korzenik, Joshua R., Young, Lawrence, Henderson, Katharine J., Jain, Dhanpat, Byrd, Boyd, Pollak, Jeffrey S., White, Robert I., Jr.
Publisher: Massachusetts Medical Society
Publication Name: The New England Journal of Medicine
Subject: Health
ISSN: 0028-4793
Year: 2000
Statistical Data Included, Risk factors, Physiological aspects, Liver diseases

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Infliximab maintenance therapy for fistulizing Crohn's disease

Article Abstract:

A study on 306 adult patients with fistulizing Crohn's disease to observe their response to induction therapy with infliximab is presented. The likelihood of a sustained response is increased if the infliximab treatment is done every eight weeks over a 54-week period.

Author: Feagan, Brian G., Fedorak, Richard N., Wild, Gary, Korzenik, Joshua R., Sands, Bruce E., Anderson, Frank H., Bernstein, Charles N., Chey, William Y., Kamm, Michael A., Lashner, Bret A., Onken, Jane E., Rachmilewitz, Daniel, Rutgeerts, Paul, Wolf, Douglas C., Marsters, Paul A., Travers, Suzanne B., Blank, Marion A., Deventer, Sander J. van
Publisher: Massachusetts Medical Society
Publication Name: The New England Journal of Medicine
Subject: Health
ISSN: 0028-4793
Year: 2004
Dosage and administration, Crohn's disease, Infliximab

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Hereditary hemorrhagic telangiectasia

Article Abstract:

Hereditary hemorrhagic telangiectasia may occur in many locations throughout the body and may respond favorably to various treatments. Telangiectasia is an abnormal permanent dilation of normal blood vessels in the skin or other mucous membranes resulting in the mixing of arterial and venous blood in the affected area and creating small red lesions. Hereditary hemorrhagic telangiectasia occurs in the stomach, intestinal tracts, brain, lung, skin, and nose. Treatments currently used for this disorder include laser therapy, transcatheter embolotherapy, vascular surgery, and estrogen therapy. Periodic evaluation for telangiectasia in the lung and brain may be advisable for otherwise affected patients. More precise identification of the genetic links to hereditary hemorrhagic telangiectasia may hold promise for future gene replacement therapy.

Author: White, Robert I., Jr., Guttmacher, Alan E., Marchuk, Douglas A.
Publisher: Massachusetts Medical Society
Publication Name: The New England Journal of Medicine
Subject: Health
ISSN: 0028-4793
Year: 1995

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Subjects list: United States, Telangiectasia, Hereditary Hemorrhagic, Hereditary hemorrhagic telangiectasia, Care and treatment
Similar abstracts:
  • Abstracts: The causes and risk of stroke in patients with asymptomatic internal-carotid-artery stenosis. Prognosis after transient monocular blindness associated with carotid-artery stenosis
  • Abstracts: Changes in umbilical venous velocities with physiologic perturbations. Fetal pericardial effusion
  • Abstracts: Restorative dentistry for pediatric teeth: state of the art 2001. Curing restorative resin: a significant controversy
  • Abstracts: Cardiac structure and function in children with human immunodeficiency virus infection treated with zidovudine
  • Abstracts: Adverse events reported following live, cold-adapted, intranasal influenza vaccine. Postlicensure Safety Surveillance for Varicella Vaccine
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.
Some parts © 2025 Advameg, Inc.